Scilex Holding Company amended a revolving line of credit with Vivasor, Inc., increasing the maximum aggregate principal amount from $20 million to $30 million. The amendment was executed on September 25, 2026, and approved by the Board of Directors and Audit Committee. No other terms were changed. Dr. Henry Ji serves as CEO of both companies. Scilex Holding Company operates in the healthcare sector, focusing on medical devices and diagnostics.
